Overcoming ABCG2-mediated drug resistance with imidazo-[1,2-b]-pyridazine-based Pim1 kinase inhibitors

R. A. Darby, A. Unsworth, S. Knapp, I. D. Kerr, R. Callaghan

    Research output: Contribution to journalArticlepeer-review

    19 Citations (Scopus)
    Original languageUndefined/Unknown
    JournalCancer Chemother Pharmacol
    Volume76
    Issue number4
    Publication statusPublished - 2015

    Cite this